Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - dinoprost trometamol - unknown - dinoprost trometamol active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - dinoprost as dinoprost trometamol - parenteral liquid/solution/suspension - dinoprost as dinoprost trometamol prostaglandin active 5.0 mg/ml - endocrine system

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - dinoprost - dinoprost 5 g/litre - endocrine agent (hormone)

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - dinoprost - solution for injection - 5 mg/ml - dinoprost - bovine, equine - food, porcine - hormone

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - dinoprostone - vaginal gel - dinoprostone 1 mg - other gynecologicals

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - dinoprostone - vaginal gel - dinoprostone 2 mg - other gynecologicals

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - dinoprost trometamol - solution for injection - 5 milligram(s)/millilitre - dinoprost - cattle, horses, pigs - hormone

United States - English - NLM (National Library of Medicine)

pharmacia and upjohn company llc - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - - prostin e2 vaginal suppository is indicated for the termination of pregnancy from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period. - prostin e2 is also indicated for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. - prostin e2 is indicated in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). - hypersensitivity to dinoprostone [see warnings and adverse reactions] - acute pelvic inflammatory disease - patients with active cardiac, pulmonary, renal, or hepatic disease

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - vaginal tablets - dinoprostone 3 mg - dinoprostone - induction of labour.

Kenya - English - Pharmacy and Poisons Board

dinoprostone - gel - each 2gm vaginal gel contains: dinoprostone 2 mg - dinoprostone